Citations for
1ASB11, BIK, CUL5
BIK ubiquitination by the E3 ligase Cul5-ASB11 determines cell fate during cellular stress.
Chen FY, Huang MY, Lin YM, Ho CH, Lin SY, Chen HY, Hung MC, Chen RH.
J Cell Biol. Sep 2;218(9):3002-3018. doi: 10.1083/jcb.201901156. Epub 2019 Aug 6 2019
2BIK
BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.
Borst A, Haferkamp S, Grimm J, Rösch M, Zhu G, Guo S, Li C, Gao T, Meierjohann S, Schrama D, Houben R.
Cancer Lett. Sep 28;404:70-78. doi: 10.1016/j.canlet.2017.07.005. Epub 2017 Jul 15 2017
3BIK, SQSTM1
Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.
Chen S, Zhou L, Zhang Y, Leng Y, Pei XY, Lin H, Jones R, Orlowski RZ, Dai Y, Grant S.
Mol Cell Biol 34(18):3435-49. doi: 10.1128/MCB.01383-13. Epub 2014 Jul 7. 2014
4BIK, TUT1
Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIα and PKCδ signaling.
Li W, Laishram RS, Ji Z, Barlow CA, Tian B, Anderson RA.
Mol Cell 45(1):25-37. doi: 10.1016/j.molcel.2011.11.017. 2012
5BIK
BIK/NBK gene as potential marker of prognostic and therapeutic target in breast cancer patients.
López-Muñoz E, Hernández-Zarco A, García-Hernández N, Alvarado-Cabrero I, Zarco-Espinosa G, Salamanca-Gómez F, Arenas-Aranda D.
Clin Transl Oncol. Aug;14(8):586-91. doi: 10.1007/s12094-012-0845-8. Epub 2012 Jul 11 2012
6BIK, HSPA5, PMAIP1
Novel mechanism of anti-apoptotic function of 78-kDa glucose-regulated protein (GRP78): endocrine resistance factor in breast cancer, through release of B-cell lymphoma 2 (BCL-2) from BCL-2-interacting killer (BIK).
Zhou H, Zhang Y, Fu Y, Chan L, Lee AS.
J Biol Chem 286(29):25687-96. Epub 2011 May 26. 2011
7BIK
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
Bodet L, Ménoret E, Descamps G, Pellat-Deceunynck C, Bataille R, Le Gouill S, Moreau P, Amiot M, Gomez-Bougie P.
Br J Cancer 103(12):1808-14. Epub 2010 Nov 9. 2010
8BIK
BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes.
Chinnadurai G, Vijayalingam S, Rashmi R.
Oncogene 27 Suppl 1:S20-9. 2008
9BIK, RHBDD1
A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.
Wang Y, Guan X, Fok KL, Li S, Zhang X, Miao S, Zong S, Koide SS, Chan HC, Wang L.
Cell Mol Life Sci 65(23):3822-9. doi: 10.1007/s00018-008-8452-0. 2008
10BIK,CASP12
Apoptosis induced by BIK was decreased with RNA interference of caspase-12.
Zhao X, Sun Y, Yu H, Ye L, Zhang L, Lu J, Yuan Y, Qian G, Ge S.
Biochem Biophys Res Commun 359(4):896-901. Epub 2007 Jun 4. 2007
11BIK
Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.
Real PJ, Sanz C, Gutierrez O, Pipaon C, Zubiaga AM, Fernandez-Luna JL.
FEBS Lett 580(25):5905-9. Epub 2006 Oct 2. 2006
12BIK
Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein.
Hur J, Bell DW, Dean KL, Coser KR, Hilario PC, Okimoto RA, Tobey EM, Smith SL, Isselbacher KJ, Shioda T.
Cancer Res 66(20):10153-61. 2006
13BIK
Mutations of the BIK gene in human peripheral B-cell lymphomas.
Arena V, Martini M, Luongo M, Capelli A, Larocca LM.
Genes Chromosomes Cancer 38(1):91-6. 2003
14TSG22A, BIK
Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK.
Gastroenterology 117(4):831-7. 1999
15BIK
Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.
Han J, Sabbatini P, White E.
Mol Cell Biol 16(10):5857-64. 1996
16BAK1, BIK
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions.
Chittenden T, et al.
EMBO J 14 : 5589-5596. 1995
17BIK
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Lutz RJ, et al.
Oncogene 11(9):1921-8. 1995